Evidence map›Paper›PMID 28291165›Full record

ArticlePancreas2017

Preoperative Treatment With FOLFIRINOX and Successful Resection for a Patient With Mixed Acinar-Endocrine Carcinoma of the Pancreas.

Motokazu Sugimoto, O Joe Hines, David W Dawson, V Raman Muthusamy, Howard A Reber, Timothy R Donahue

Open access · greenAbstract readCase ReportsLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Pancreas, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Motokazu SugimotoDepartment of Surgery, UCLA Medical Center, Los Angeles, CA Department of Pathology and Laboratory Medicine, UCLA Medical Center, Los Angeles, CA Division of Digestive Diseases, UCLA Medical Center, Los Angeles, CA Department of Surgery, UCLA Medical Center, Los Angeles, CA, tdonahue@mednet.ucla.edu.
O Joe Hines
David W Dawson
V Raman Muthusamy
Howard A Reber
Timothy R Donahue
UCLA Medical Center · US

Funding

PET Imaging-guided Personalized Therapy in Pancreatic CancerR01CA187678 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CZERNIN, JOHANNES, DONAHUE, TIMOTHY R · 2014 to 2018
$2.8M
UCLA Multifunctional Mesoporous Silica Nanoparticle Platform for Treatment of Pancreas CancerU01CA198846 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DONAHUE, TIMOTHY R, MENG, HUAN · 2015 to 2019
$2.4M
NCI NIH HHS R01 CA187678NCI NIH HHS U01 CA198846
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic Combined Chemotherapy ProtocolsCamptothecinCarcinoma, Acinar CellCarcinoma, Islet CellCombined Modality TherapyFluorouracilHumansIrinotecanLaparotomyLeucovorinMaleMiddle AgedOrganoplatinum CompoundsOxaliplatinPancreasPancreatic NeoplasmsCamptothecinFluorouracilIrinotecanLeucovorinOrganoplatinum CompoundsOxaliplatin

Identifiers

PMID28291165
PMCPMC5354082
OpenAlexW2592068905

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.